Le Lézard
Classified in: Health, Business
Subject: TNM

Hain Celestial Completes the Sale of Thinsters® Cookie Brand to J&J Snack Foods


HOBOKEN, N.J., April 9, 2024 /PRNewswire/ -- The Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, announced today that it has completed the sale of its Thinsters® cookie business to J&J Snack Foods. The all-cash transaction that closed on April 8, 2024, further optimizes the company's better-for-you portfolio and will be used to pay down company debt. 

The Hain Celestial Group, Inc.

"Divesting Thinsters further streamlines our supply chain network and strengthens our ability to focus our efforts on driving greater reach and scale of our core better-for-you brands across our categories of focus," said Wendy Davidson, Hain Celestial President and CEO. "We are pleased to reach this agreement with J&J Snack Foods and are confident that the business will thrive under their leadership."

In September 2023 Hain introduced Hain Reimagined, the company's multi-year transformation plan to pivot the business to growth. The strategy is grounded in executing four core pillars: Focus, Grow, Build and Fuel. The Thinsters divestiture contributes to the Focus Pillar as it further refines Hain's uniquely positioned portfolio of better-for-you brands across five growth categories: snacks, baby & kids food, beverages, meal preparation and personal care. The company will continue to identify opportunities to progress its Focus Pillar efforts through operating model optimization and aligning its footprint in five core geographies, the U.S., Canada, UK, Ireland and Western Europe.

About The Hain Celestial Group
Hain Celestial Group is a leading health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, our portfolio of beloved brands has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial's products across snacks, baby/kids, beverages, meal preparation, and personal care, are marketed and sold in over 75 countries around the world. Our leading brands include Garden Veggietm snacks, Terra® chips, Garden of Eatin'® snacks, Earth's Best® and Ella's Kitchen® baby and kids foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, Greek Gods® yogurt, Cully & Sully®, Imagine® and New Covent Garden® soups, Yves® and Linda McCartney's® (under license) meat-free, and Alba Botanica® natural sun care, among others. For more information, visit hain.com and LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties, and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words "will" "expect," "aim," "may," "should," "plan," "intend," "potential" and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives; and our business strategy.

The risks and uncertainties that may cause actual results to differ materially from forward-looking statements are described in our most recent Annual Report on Form 10-K and our other filings from time to time with the U.S. Securities and Exchange Commission.

We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.

Logo - https://mma.prnewswire.com/media/450862/Hain_Celestial_Logo_v1.jpg


These press releases may also interest you

at 05:00
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well...

at 04:21
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...

at 04:00
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...

at 04:00
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...

at 03:44
21st.BIO unveiled a new pilot plant facility in its Danish...

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...



News published on and distributed by: